ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

TeleVox Acquires Odeza Patient Engagement Business from Ensemble Health Partners

MOBILE, Ala., Sept. 05, 2023 (GLOBE NEWSWIRE) -- TeleVox, the industry-leading provider of omnichannel digital patient engagement technology, has acquired the Odeza patient engagement business from Ensemble Health Partners (Ensemble), the leading revenue cycle management company for hospitals, health systems and physician practices.

Additionally, TeleVox and Ensemble will make TeleVox’s technology available to Ensemble’s customers, offering healthcare providers a comprehensive solution from patient acquisition to discharge and beyond.

“We welcome Odeza into the TeleVox family and the acquisition of their patient engagement business aligns with our 30 plus year commitment to providing tailored communication solutions that improve the patient experience and make TeleVox the industry leader,” said Vik Krishnan, President of TeleVox. “By making our patient engagement offerings available to the expansive customer base of Ensemble, we’ll help more healthcare providers deliver exceptional care to their patients.”

Today’s news continues a string of rapid growth and expansion for TeleVox. In April, TeleVox announced the launch of Iris™, an AI-enabled omnichannel conversational virtual assistant for healthcare providers. That announcement was followed a month later with the launch of its automated reputation management solution that empowers hospitals, health systems, and physician practices to take control of their online presence.

“This partnership strengthens each of our positions in the healthcare industry and delivers unmatched value to our customers,” said Judson Ivy, Founder, President and CEO of Ensemble Health Partners.

For more information about TeleVox solutions, please visit www.televox.com/request-a-demo.

About TeleVox
TeleVox is a leading provider of omnichannel digital patient engagement technology. Our solutions are used by more than 10,000 healthcare organizations—from hospitals and health systems to community health centers—to engage, educate, and empower patients throughout their care journey. Our patient engagement platform integrates with the electronic health record (EHR) to support automated, personalized, two-way interactions with patients. And our pharmaceutical team partners with life science companies to develop strategic disease state awareness, education, and vaccination reminders by reaching more patients through customized communication. All of these exchanges are possible via text, virtual assistant, interactive voice response (IVR), email, and postcards. For 30 years, TeleVox has helped preserve care continuity, reduce the operational burden on staff, and drive revenue while making the healthcare communication process easier for everyone. TeleVox is a part of West Technology Group, LLC controlled by affiliates of certain funds managed by Apollo Global Management, Inc. (NYSE: APO).

Learn more at www.televox.com.

About Ensemble Health Partners
Ensemble Health Partners is a full-service revenue cycle management company, delivering a holistic approach to financial health for more than 20 healthcare provider clients across the country. Ensemble provides a complete platform of services, technology, business intelligence and analytics to manage every aspect of revenue cycle operations so healthcare providers can focus on delivering exceptional patient care in their communities.

Contact
Donald Thompson
Head of Marketing
Donald.thompson@televox.com
(315) 720-3304


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.